Clinical Trial Update: Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating capecitabine plus bendamustine in women with pretreated locally advanced or metastatic HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bendamustine (Bendamustine)
• Capecitabine (capecitabine)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED